Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Bioventus Inc. - SIC # 3850 -
Ticker
Exchange
SIC #
Website
Latest Ticker
BVS
Nasdaq
3850
www.bioventus.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Bioventus Inc.
Are Investors Undervaluing Bioventus (BVS) Right Now?
- Jun 9th, 2026 7:40 am
Bioventus Highlights PNS, PRP Growth as Cash Flow Improves and Debt Falls
- Jun 8th, 2026 5:03 pm
Are Medical Stocks Lagging Allarity Therapeutics, Inc. (ALLR) This Year?
- Jun 3rd, 2026 7:40 am
After Plunging 22% in 4 Weeks, Here's Why the Trend Might Reverse for Bioventus (BVS)
- Jun 2nd, 2026 7:35 am
Bioventus to Present at the Goldman Sachs 47TH Annual Global Healthcare Conference
- Jun 2nd, 2026 5:00 am
Bioventus (BVS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
- May 29th, 2026 7:55 am
Is Bioventus (BVS) Stock Undervalued Right Now?
- May 21st, 2026 7:40 am
Are Medical Stocks Lagging Bioventus (BVS) This Year?
- May 18th, 2026 7:40 am
Consumer Sentiment Just Crashed Below the Recession Threshold. These 3 Defensive Stocks Under $25 Are Built for What Comes Next
- May 14th, 2026 9:47 am
Bioventus' (NASDAQ:BVS) Solid Earnings Are Supported By Other Strong Factors
- May 14th, 2026 6:12 am
Wall Street Analysts See a 38.97% Upside in Bioventus (BVS): Can the Stock Really Move This High?
- May 8th, 2026 7:55 am
Bioventus Inc. Q1 2026 Earnings Call Summary
- May 6th, 2026 2:48 pm
Bioventus (BVS) Q1 2026 Earnings Transcript
- May 6th, 2026 1:49 pm
Bioventus Q1 Earnings Call Highlights
- May 6th, 2026 8:55 am
Bioventus (BVS) Surpasses Q1 Earnings and Revenue Estimates
- May 6th, 2026 7:05 am
Bioventus Reports First Quarter Financial Results
- May 6th, 2026 5:30 am
Should Value Investors Buy Bioventus (BVS) Stock?
- May 5th, 2026 7:40 am
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
- Apr 30th, 2026 2:43 pm
Are Investors Undervaluing Amneal Pharmaceuticals (AMRX) Right Now?
- Apr 29th, 2026 7:40 am
Bioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026
- Apr 28th, 2026 2:15 pm
Scroll